Nukast AB Tablet SR
Images are for reference. Actual packaging may vary.
1 units • OtherPrescription requiredSchedule H
Nukast AB Tablet SR
Acebrophylline (200mg) + Montelukast (10mg)
₹271.70
1 units • Other
A valid prescription is required for this medicine.
1
Delivery
Safe & Secure
Easy Returns
24/7 Support
SMARTER CARE
A little guidance.
A better choice.
Haven’t found an alternative? A health advisor can help you understand what to do next.
No matching alternative found
We haven't found a cheaper matching alternative in our catalogue right now. Our health advisors can help you explore other options.
Active composition
Montelukast 10 mg
+1 more active ingredient
How It Works
Montelukast selectively antagonizes leukotriene receptors, inhibiting their effects on bronchoconstriction and inflammation.
Acebrophylline enhances mucociliary clearance by reducing mucus viscosity and promoting airway relaxation.
Medicine Strength
10 mg
All Active Ingredients
Montelukast10 mg
Acebrophylline200 mg
Uses & Benefits
Medical applications
Anti-inflammatoryInflammationHeadacheAllergic
Nukast AB Tablet SR is a combination medication containing Acebrophylline 200mg and Montelukast 10mg, formulated to provide sustained relief in respiratory conditions characterized by bronchoconstriction and inflammation. Acebrophylline acts as a bronchodilator with mucolytic properties, facilitating airway clearance by reducing mucus viscosity and improving respiratory function.
Read full descriptionShow less
Montelukast, a leukotriene receptor antagonist, effectively inhibits leukotriene-mediated bronchoconstriction and inflammation, contributing to long-term control of asthma and allergic rhinitis symptoms. This synergistic combination is indicated for the management of chronic obstructive pulmonary disease (COPD), bronchial asthma, and other obstructive airway diseases where both bronchospasm and airway inflammation coexist.
Nukast AB Tablet SR is designed for once-daily administration, ensuring sustained therapeutic plasma levels and improved patient compliance. It is generally well-tolerated; however, clinicians should monitor for potential adverse effects such as headache, gastrointestinal disturbances, or hypersensitivity reactions. It is contraindicated in patients with known hypersensitivity to either component.
As with all bronchodilators and anti-inflammatory agents, careful assessment of patient history and concurrent medications is essential to minimize drug interactions and optimize therapeutic outcomes. Nukast AB Tablet SR should be used under medical supervision, with dosage adjustments based on clinical response.
Dosage & How to Use
How to use Nukast AB Tablet IR Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Nukast AB Tablet SR may be taken with or without food, but it is better to take it at a fixed time.
Safety Advice
Important precautions
Side effects
Side-effect information is not available for this medicine. Please consult your doctor or pharmacist.
Safety Advice
Alcohol
Caution is advised when consuming alcohol with Nukast AB Tablet SR. Please consult your doctor.
High Risk
Pregnancy
Information regarding the use of Nukast AB Tablet SR during pregnancy is not available. Please consult your doctor.
Medical Advice
Driving
It is not known whether Nukast AB Tablet SR alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Exercise Caution
Liver
Nukast AB Tablet SR should be used with caution in patients with liver disease. Dose adjustment of Nukast AB Tablet SR may be needed. Please consult your doctor.
Regular Checkup
Breastfeeding
Information regarding the use of Nukast AB Tablet SR during breastfeeding is not available. Please consult your doctor.
Consult Doctor
Kidney
Nukast AB Tablet SR should be used with caution in patients with kidney disease. Dose adjustment of Nukast AB Tablet SR may be needed. Please consult your doctor.
Regular Checkup
Customer Reviews
0 reviews for Nukast AB Tablet SR
